288-23928-83832 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-20
Registered in v-safe
2020-12-20
Dose 1 — Pfizer-BioNTech
2020-12-20
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-21
Survey response — days 1–6 daily, dose 1
MedDRA: Taste disorder — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to work

Free text: change in sense of taste (mild). All symptoms worse 12 hours after & have since improved.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-21
Report sent to call center — days 1–6 daily, dose 1
Be unable to work

1 call case(s)
2020-12-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-27
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-03
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-08
Dose 2 — Pfizer-BioNTech
2021-01-10
Survey response — days 1–6 daily, dose 2
MedDRA: Arthralgia, Chills, Fatigue, Headache, Lymphadenopathy, Muscle swelling, Myalgia, Pyrexia, Thirst — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: This check in is 2 days after injection, so symptoms mostly resolved. Worth reporting that symptoms the night of injection were severe: myalgia, arthralgia, fever, chills, whole body lymphadenopathy, muscle swelling, headache, fatigue, thirst

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-10
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-12
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-15
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-01-22
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-01-29
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-05
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-12
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-19
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-09
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-09
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-08
Dose 3 — Moderna
2022-01-08
Health check-in — day 0, dose 3
Feeling: Fair · Site: Pain · None

Adult check-in
2022-01-08
Survey response — 12 months, dose 2
MedDRA: Injection site pain — Feeling: Fair

Free text: Sore arm at booster dose site

MedDRA releases: 2024-11 · check-in free text available
2022-01-09
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-01-10
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · Headache

Adult check-in
2022-01-11
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches

Adult check-in
2022-01-13
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-14
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-15
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2022-01-22
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-01-29
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-02-05
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-02-12
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-02-19
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-04-09
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-07-09
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2023-01-08
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-20	Pfizer-BioNTech
2	2021-01-08	Pfizer-BioNTech
3	2022-01-08	Moderna	No

Call center

Reported	Outcome	VAERS-related outcome
2020-12-21	priority 2/3
2021-01-10	priority 2/3

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-21

Systemic reaction (other): change in sense of taste (mild). All symptoms worse 12 hours after & have since improved.

Release 1 — days 1–6 daily, dose 2

2021-01-10

Systemic reaction (other): This check in is 2 days after injection, so symptoms mostly resolved. Worth reporting that symptoms the night of injection were severe: myalgia, arthralgia, fever, chills, whole body lymphadenopathy, muscle swelling, headache, fatigue, thirst

Release 10 — 12 months, dose 2

2022-01-08

Symptoms: Sore arm at booster dose site

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Injection site pain	·	·	✓
SRO	Arthralgia	✓	✓	✓
SRO	Chills	✓	✓	✓
SRO	Fatigue	✓	✓	✓
SRO	Headache	✓	✓	✓
SRO	Lymphadenopathy	✓	✓	✓
SRO	Muscle swelling	✓	✓	✓
SRO	Myalgia	✓	✓	✓
SRO	Pyrexia	✓	✓	✓
SRO	Taste disorder	✓	✓	✓
SRO	Thirst	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release